Roger S. McIntyre, MD; Mehala Subramaniapillai, MSc; Yena Lee, HBSc; et al.
free access
JAMA Psychiatry. 2019;76(8):783-790. doi:10.1001/jamapsychiatry.2019.0779
This randomized clinical trial compares the efficacy of infliximab therapy vs placebo in improving depressive symptoms among adults with bipolar depression in Canada and the United States.
Sonya B. Norman, PhD; Ryan Trim, PhD; Moira Haller, PhD; et al.
free access
JAMA Psychiatry. 2019;76(8):791-799. doi:10.1001/jamapsychiatry.2019.0638
This randomized clinical trial of veterans compares the efficacy of integrated prolonged exposure therapy with present-centered integrated coping skills therapy in reducing posttraumatic stress disorder (PTSD) symptoms and alcohol use.
Lauren Breithaupt, MA; Ole Köhler-Forsberg, MD; Janne Tidselbak Larsen, MSc; et al.
free access
JAMA Psychiatry. 2019;76(8):800-809. doi:10.1001/jamapsychiatry.2019.0297
This cohort study of adolescent girls evaluates the association of hospitalization for infections and treatment with anti-infective agents with the risk of an eating disorder diagnosis in Danish adolescent girls.
Jason M. Hockenberry, PhD; Peter Joski, MS; Courtney Yarbrough, PhD; et al.
free access
JAMA Psychiatry. 2019;76(8):810-817. doi:10.1001/jamapsychiatry.2019.0633
This analysis of national Medical Expenditure Panel Survey data examines trends in outpatient treatment of depression in the United States from 1998 to 2015.
Kimberley Marie Kendall, MBBCh; Elliott Rees, PhD; Matthew Bracher-Smith, BSc; et al.
open access
JAMA Psychiatry. 2019;76(8):818-825. doi:10.1001/jamapsychiatry.2019.0566
This case-control study examines the variables that affect depression among individuals of European ancestry in the UK Biobank study who carry copy number variants associated with neurodevelopmental disorders.
Elizabeth D. Ballard, PhD; Lihong Cui, MSc; Caroline Vandeleur, PhD; et al.
free access
JAMA Psychiatry. 2019;76(8):826-833. doi:10.1001/jamapsychiatry.2019.0248
This study examines participant data from the National Institute of Mental Health family study in the United States and the PsyCoLaus family study in Lausanne, Switzerland, for underlying mental disorders and history of suicidal behavior among adults in the same family.
Beate Leppert, PhD; Alexandra Havdahl, PhD; Lucy Riglin, PhD; et al.
open access
JAMA Psychiatry. 2019;76(8):834-842. doi:10.1001/jamapsychiatry.2019.0774
This population-based cohort study assesses whether maternal polygenic risk scores for neurodevelopmental disorders are associated with early-life exposures previously linked to the disorders in women with available genotype data.
Jianjun Zhu, MS; Steven B. Lowen, PhD; Carl M. Anderson, PhD; et al.
free access
JAMA Psychiatry. 2019;76(8):843-853. doi:10.1001/jamapsychiatry.2019.0931
This cohort study assesses association of the type and age of exposure to childhood maltreatment with hyperactive and hypoactive amygdala responses in young adults.
Diego A. Pizzagalli, PhD; Sabina Berretta, MD; Dustin Wooten, PhD; et al.
free access
JAMA Psychiatry. 2019;76(8):854-861. doi:10.1001/jamapsychiatry.2019.0801
This cross-sectional study explores dopamine transporter availability in individuals with major depressive disorder who were not taking medication and levels of dopamine transporter expression in postmortem tissues from donors with major depressive disorder who died by suicide.